- Comparison of CBF Measured with Combined Velocity-Selective Arterial Spin-Labeling and Pulsed Arterial Spin-Labeling to Blood Flow Patterns Assessed by Conventional Angiography in Pediatric Moyamoya
This study assesses the accuracy of combined velocity-selective arterial spin-labeling and traditional pulsed arterial spin-labeling CBF measurements in pediatric Moyamoya disease, with comparison with blood flow patterns on conventional angiography. Twenty-two neurologically stable pediatric patients with Moyamoya disease and 5 asymptomatic siblings without frank Moyamoya disease were imaged with velocity-selective arterial spin-labeling, pulsed arterial spin-labeling, and DSA (patients). Qualitatively, velocity-selective arterial spin-labeling perfusion maps reflect the DSA parenchymal phase, regardless of postinjection timing. Conversely, pulsed arterial spin-labeling maps reflect the DSA appearance at postinjection times closer to pulsed arterial spin-labeling postlabeling delay, regardless of vascular phase. ASPECTS comparison showed excellent agreement between arterial spin-labeling and DSA, suggesting velocity-selective arterial spin-labeling and pulsed arterial spin-labeling capture key perfusion and transit delay information, respectively. Velocity-selective arterial spin-labeling offers a powerful approach to image perfusion in pediatric Moyamoya disease due to transit delay insensitivity.
- Perfusion MRI-Based Fractional Tumor Burden Differentiates between Tumor and Treatment Effect in Recurrent Glioblastomas and Informs Clinical Decision-Making
Forty-seven patients with high-grade gliomas (primarily glioblastoma) with recurrent contrast-enhancing lesions on DSC-MR imaging were retrospectively evaluated after surgical sampling. Histopathologic examination defined treatment effect versus tumor. Normalized relative CBV thresholds of 1.0 and 1.75 were used to define low, intermediate, and high fractional tumor burden classes in each histopathologically defined group. Performance was assessed with an area under the receiver operating characteristic curve. Mean low fractional tumor burden, high fractional tumor burden, and relative CBV of the contrast-enhancing volume were significantly different between treatment effect and tumor with tumor having significantly higher fractional tumor burden and relative CBV and lower fractional tumor burden. High fractional tumor burden and low fractional tumor burden define fractions of the contrast-enhancing lesion volume with high and low blood volume, respectively, and can differentiate treatment effect from tumor in recurrent glioblastomas. Fractional tumor burden maps can also help to inform clinical decision-making.
Welcome to the new AJNR, Updated Hall of Fame, and more. Read the full announcements.
AJNR is seeking candidates for the position of Associate Section Editor, AJNR Case Collection. Read the full announcement.